<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260122068635N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-02-16</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Comparing the effectiveness of narrative exposure therapy and integrated transdiagnostic therapy</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the effectiveness of narrative exposure therapy and integrated transdiagnostic therapy on self-esteem, emotional alexithymia, self-harming behaviors, and cognitive fusion in female students who are victims of domestic violence</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-02-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/88765</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Students who are eligible and have the opportunity to cooperate will be selected based on a purposeful non-random method, and among them, 45 students will be selected by simple random method (drawing) and the randomization unit will be the same person, and then they will be divided into three groups (two experimental groups and one control group).</study_design>
      <phase>N/A</phase>
      <hc_freetext>Domestic violence.</hc_freetext>
      <i_freetext>Intervention 1: First intervention group: Narrative exposure therapy, first session: introduction, explanation of the intervention and expectations from the group, introduction of skills, statement of goal, comprehensive assessment, establishment of good relationship, familiarization with narrative therapy, case study, life narrative and description of problematic stories. Second session: objectification and externalization of the problem, naming the problem, identifying problematic words and beginning metaphor-making. Third session: continuation of metaphor-making, examination of problematic metaphors and their relationship with the life narrative and taking a position on the problem, beginning deconstruction. Fourth session: Destruction phase: Destruction of the problem by life exceptions, narrative analysis, attitude towards the problem and the mutual effects of the individual and the problem. Fifth session: Reconstruction: new metaphors, mental representations of life situations with a new metaphor, creation of reality by the individual and beginning narrative-making. Sixth session: Enrichment of the new story using unique strategies, examination of the story and its meaning for the future. Seventh session: Consolidation phase: Living in the new story, answering questions and rewriting. Stories from the past, Session 8: Examining the meaning of life, external documentation, enriching and encouraging the individual to continue the story, conducting a post-test. Intervention 2: Second intervention group: Session 1: Increasing motivation and engagement with treatment Session 2: Psychological training and tracking of emotional experiences Session 3: Emotional awareness training Session 4: Cognitive reappraisal Session 5: Emotional avoidance and emotion-induced behaviors Session 6: Awareness and tolerance of physical feelings Session 7: Situation-based visceral and emotional confrontation Session 8: Relapse prevention. Intervention 3: Control group: No intervention will be made.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is The data information is confidential and I do not intend to publish it.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>mitra shamsi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>National Drilling Town, No. 18, Fatah 1 Street</address>
        <city>ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۶۱۶۶۶۳۸۳۶۱</zip>
        <telephone>+98 61 3334 8320</telephone>
        <email>artiim.sh@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Fariba Hafezi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Farhangshahr, Islamic Azad University, Ahvaz Branch</address>
        <city>ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۶۱۳۴۹-۳۷۳۳۳</zip>
        <telephone>+98 61 3334 8320</telephone>
        <email>dr.haffezi@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age range 15 to 18 years
Having a history of physical violence from parents and caregivers
Having a history of mental or emotional problems from parents or caregivers</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>18 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Current diagnosis of psychosis, bipolar disorder, or severe neurodevelopmental disorders
Taking medications such as antidepressants or tranquilizers</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R45.6</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Physical violence</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First intervention group: Narrative exposure therapy, first session: introduction, explanation of the intervention and expectations from the group, introduction of skills, statement of goal, comprehensive assessment, establishment of good relationship, familiarization with narrative therapy, case study, life narrative and description of problematic stories. Second session: objectification and externalization of the problem, naming the problem, identifying problematic words and beginning metaphor-making. Third session: continuation of metaphor-making, examination of problematic metaphors and their relationship with the life narrative and taking a position on the problem, beginning deconstruction. Fourth session: Destruction phase: Destruction of the problem by life exceptions, narrative analysis, attitude towards the problem and the mutual effects of the individual and the problem. Fifth session: Reconstruction: new metaphors, mental representations of life situations with a new metaphor, creation of reality by the individual and beginning narrative-making. Sixth session: Enrichment of the new story using unique strategies, examination of the story and its meaning for the future. Seventh session: Consolidation phase: Living in the new story, answering questions and rewriting. Stories from the past, Session 8: Examining the meaning of life, external documentation, enriching and encouraging the individual to continue the story, conducting a post-test.</i_keyword>
      <i_keyword>Second intervention group: Session 1: Increasing motivation and engagement with treatment Session 2: Psychological training and tracking of emotional experiences Session 3: Emotional awareness training Session 4: Cognitive reappraisal Session 5: Emotional avoidance and emotion-induced behaviors Session 6: Awareness and tolerance of physical feelings Session 7: Situation-based visceral and emotional confrontation Session 8: Relapse prevention</i_keyword>
      <i_keyword>Control group: No intervention will be made.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Domestic violence. Timepoint: Before intervention, after intervention, two months after intervention. Method of measurement: The score that the subject will obtain from the Haj-Yahya (2001) Domestic Violence Questionnaire.</prim_outcome>
      <prim_outcome>Self-esteem. Timepoint: Before intervention, after intervention, two months after intervention. Method of measurement: The score that the subject will obtain from the Rosenberg Self-Esteem Questionnaire (1965).</prim_outcome>
      <prim_outcome>Emotional alexithymia. Timepoint: Before intervention, after intervention, two months after intervention. Method of measurement: It is the score that the subject will obtain from the Bigby et al. (1994) Emotional Alexithymia Questionnaire.</prim_outcome>
      <prim_outcome>Self-harming behaviors. Timepoint: Before intervention, after intervention, two months after intervention. Method of measurement: The score that the subject will obtain from the Sanson et al. (1998) Self-Injurious Behaviors Questionnaire.</prim_outcome>
      <prim_outcome>Cognitive fusion. Timepoint: Before intervention, after intervention, two months after intervention. Method of measurement: The score that the subject will obtain from the cognitive fusion questionnaire of Gillanders et al. (2014).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-01-14</approval_date>
        <contact_name>Ethics Committee of Islamic Azad University of Ahvaz Branch</contact_name>
        <contact_address>Farhang Shahr , Islamic Azad University, Ahvaz, Golestan HighwayBranch, ahvaz Khouzestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
